![](/img/cover-not-exists.png)
Early onset HER2-positive breast cancer is associated with germline TP53 mutations
Amal Melhem-Bertrandt, Jasmina Bojadzieva, Kaylene J. Ready, Elias Obeid, Diane D. Liu, Angelica M. Gutierrez-Barrera, Jennifer K. Litton, Olufunmilayo I. Olopade, Gabriel N. Hortobagyi, Louise C. StrVolume:
118
Year:
2012
Language:
english
Pages:
6
DOI:
10.1002/cncr.26377
File:
PDF, 771 KB
english, 2012